mCart

mCart is an artificial intelligence-based technology platform developed by Mavatar to address global healthcare challenges. According to the vendor, it is designed to assist healthcare professionals, researchers, pharmaceutical and biotechnology companies, clinical research organizations, and academic and research institutions. By leveraging AI algorithms and big biomedical datasets, mCart aims to revolutionize precision medicine, drug development, and personalized therapies. The platform is intended to offer innovative solutions to potentially improve patient outcomes and reduce healthcare costs.

Key Features

According to the vendor, mCart utilizes AI algorithms, including deep neural networks, to analyze big biomedical datasets and uncover potential biological signatures. This is said to enable a better understanding of cellular pathways, disease mechanisms, and the identification of potential drug targets, mechanisms of action, and biomarkers.

The vendor claims that mCart constructs network models, known as Digital Twins, from genomic data, phenotypic information, and relevant environmental factors. These Digital Twins are computational models of complex systems, allowing for the testing of thousands of drugs on the patients' Digital Twins to potentially match patients with optimal treatments.

According to the vendor, mCart aids in target selection, combination treatment, and understanding the mechanism of action by compiling large databases from clinical and biomedical studies. The AI-driven analysis can also be applied to existing drugs on the market to potentially discover new indications, expanding their potential applications.

The vendor states that mCart's AI-based diagnostic tool supports clinicians in matching patients with potential optimal treatments. By constructing network models or Digital Twins from genomic data and relevant disease mechanisms, mCart aims to provide insights into potential effective treatment options for individual patients with complex diseases.

According to the vendor, mCart leverages single-cell RNA sequencing to create billions of digital twins of patients with complex diseases. By analyzing these digital twins, mCart aims to identify potential optimal treatments for each patient, potentially accelerating recovery and avoiding needless suffering. The platform also aims to enable the discovery of potential hidden information in big data analyses, supporting precision medicine and drug development projects.